Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy.

Suhail N, Bilal N, Khan HY, Hasan S, Sharma S, Khan F, Mansoor T, Banu N.

J Clin Pharm Ther. 2012 Feb;37(1):22-6. doi: 10.1111/j.1365-2710.2010.01237.x. Epub 2011 Jan 4.

PMID:
21204889
2.

A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy.

Clemons MJ, Marshall E, Dürig J, Watanabe K, Howell A, Miles D, Earl H, Kiernan J, Griffiths A, Towlson K, DeTakats P, Testa NG, Dougal M, Hunter MG, Wood LM, Czaplewski LG, Millar A, Dexter TM, Lord BI.

Blood. 1998 Sep 1;92(5):1532-40.

3.

Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain.

Zaidi SM, Banu N.

Clin Chim Acta. 2004 Feb;340(1-2):229-33.

PMID:
14734217
4.

Vitamins C and E treatment combined with exercise modulates oxidative stress markers in blood of patients with fibromyalgia: a controlled clinical pilot study.

Nazıroğlu M, Akkuş S, Soyupek F, Yalman K, Çelik Ö, Eriş S, Uslusoy GA.

Stress. 2010 Nov;13(6):498-505. doi: 10.3109/10253890.2010.486064. Epub 2010 Jul 28.

PMID:
20666654
5.

Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease.

Rivera E, Holmes FA, Buzdar AU, Asmar L, Kau SW, Fraschini G, Walters R, Theriault RL, Hortobagyi GN.

Breast J. 2002 Jan-Feb;8(1):2-9.

PMID:
11856154
6.
7.

Effect of vitamin E and C supplements on antioxidant defense system in cardiovascular disease patients in Zahedan, southeast Iran.

Karajibani M, Hashemi M, Montazerifar F, Dikshit M.

J Nutr Sci Vitaminol (Tokyo). 2010;56(6):436-40.

8.
9.
11.
12.

DNA damage in peripheral blood lymphocytes in patients during combined chemotherapy for breast cancer.

Sánchez-Suárez P, Ostrosky-Wegman P, Gallegos-Hernández F, Peñarroja-Flores R, Toledo-García J, Bravo JL, Del Castillo ER, Benítez-Bribiesca L.

Mutat Res. 2008 Apr 2;640(1-2):8-15. doi: 10.1016/j.mrfmmm.2007.11.008. Epub 2007 Dec 8.

PMID:
18207203
13.

[Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children].

Zhang M, Ma AG, Zhang XZ, Ge S, Shi XX.

Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Apr;26(4):268-72. Chinese.

PMID:
15941534
14.
15.

Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.

Calabresi F, Di Lauro L, Marolla P, Curcio CG, Paoletti G, Calabró A, Giannarelli D, Ballatore P, Foggi CM, Di Palma M, et al.

Semin Oncol. 1991 Apr;18(2 Suppl 4):66-72.

PMID:
2031201
16.

Influence of therapy on the antioxidant status in patients with melanoma.

Gadjeva V, Dimov A, Georgieva N.

J Clin Pharm Ther. 2008 Apr;33(2):179-85. doi: 10.1111/j.1365-2710.2008.00909.x.

PMID:
18315784
17.

The effects of hormone replacement therapy combined with vitamins C and E on antioxidants levels and lipid profiles in postmenopausal women with Type 2 diabetes.

Naziroğlu M, Simşek M, Simşek H, Aydilek N, Ozcan Z, Atilgan R.

Clin Chim Acta. 2004 Jun;344(1-2):63-71.

PMID:
15149872
18.

Dietary vitamin C and E modulates oxidative stress induced-kidney and lens injury in diabetic aged male rats through modulating glucose homeostasis and antioxidant systems.

Özkaya D, Naziroğlu M, Armağan A, Demirel A, Köroglu BK, Çolakoğlu N, Kükner A, Sönmez TT.

Cell Biochem Funct. 2011 Jun;29(4):287-93. doi: 10.1002/cbf.1749. Epub 2011 Mar 18.

PMID:
21416480
19.

Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer.

Qi M, Li JF, Xie YT, Lu AP, Lin BY, Ouyang T.

Breast Cancer Res Treat. 2010 Aug;123(1):197-202. doi: 10.1007/s10549-010-1000-2. Epub 2010 Jun 26.

PMID:
20582466
20.

The efficacy and safety of neoadjuvant chemotherapy +/- letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial.

Mohammadianpanah M, Ashouri Y, Hoseini S, Amadloo N, Talei A, Tahmasebi S, Nasrolahi H, Mosalaei A, Omidvari S, Ansari M, Mosleh-Shirazi MA.

Breast Cancer Res Treat. 2012 Apr;132(3):853-61. doi: 10.1007/s10549-011-1814-6. Epub 2011 Oct 16.

PMID:
22002564

Supplemental Content

Support Center